National and Kapodistrian University of Athens
Σχεδιασμός και αξιολόγηση χιμαιρικών νανοσυστημάτων μεταφοράς δοξορουβικίνης με συνδυασμό λιποσωμάτων και υπερδιακλαδισμένων πολυμερών
Abstract
dc:descriptionIn the past decades, the encapsulation of anticancer active pharmaceutical ingredients in nanocarriers has attracted great research interest. The goal is to improve their therapeutic activity, decrease the adverse effects that result from their activity in healthy tissues and cells, and control their retention time inside the body. However, the developed carriers fail to reach clinical practice due to their inability to fulfill specific requirements (e.g. drug encapsulation efficiency, size, surface charge, surface hydrophilicity etc.).Recently a new class of carriers has emerged, called chimeric carriers. They are produced by the combination of two different nanocarriers, aiming at the improvement of the systems’ properties, such as drug encapsulation efficiency and release rate. Systems produced by the combination of liposomes and dendrimers, named “liposome “locked-in” dendrimers”, belong to this class. In these systems, the incorporation of dendrimers in liposomes increased the encapsulation efficiency of the anticancer drug doxorubicin (DOX) and controlled its release rate. The mechanism through which these actions occur, as well as the interactions that take place between the carriers structural components and result in their ameliorated characteristics, have not been fully explored. The purpose of the present doctoral thesis is the development of a new nanocarrier for anticancer drugs prepared by the combination of liposomes and hyperbranched polymers (HBPs), the in-depth investigation of the interactions that take place between the individual components of the final carrier and the clarification of the parameters that affect its final properties. The aforementioned information can be used later on for the design of such drug delivery carriers and the prediction of their properties. As an active pharmaceutical ingredient, the anticancer drug DOX was chosen and as dendritic polymers, different pseudogeneration of HBPs belonging to the class of aliphatic polyesters were used. For studying both the interactions between liposomes, HBPs and DOX and the properties of the final carriers, advanced analytical techniques were used such as Differential Scanning Calorimetry (m-DSC), Fourier Transform Infrared – Attenuated Total Reflectance Spectroscopy (ATR-FTIR), Pulsed-Gradient Spin Echo-NMR (PGSE-NMR), Atomic Force Microscopy (AFM) and Electron Paramagnetic Resonance (EPR). From these studies the following parameters were determined: (1) the optimum composition of the final carriers (liposome phospholipid composition and percentage of incorporated HPBs depending on their pseudogeneration number), (2) DOX encapsulation efficiency and release rate, (3) interactions between phospholipids, HBPs and DOX that affect drug encapsulation and release as well as the stability of the dug carrier and (4) the effect of other formulation parameters such as the presence of high concentrations of sucrose and osmotic pressure differences either-side of the liposomal lipid bilayer. Finally, HBPs terminal groups were modified (from hydroxyl to carboxyl groups) and the effect of the nature of these groups on drug encapsulation efficiency was investigated.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mourelatou, Elena
- Μουρελάτου, Έλενα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39817